HKMPY (HKMPY) Stock Price & Analysis
HKMPY (HKMPY) rose 0.00% to USD 39.08 as of June 10, 2026 at 00:49 UTC, according to Nexqual real-time market data.
HKMPY last closed at USD 39.08; the session ranged USD 39.08–39.08 on volume of 222 shares. Market capitalization is $4.14B, with a 52-week range of USD 31.8–56.91 (PNK). Source: Nexqual, June 10, 2026 at 00:49 UTC.
Key Statistics (as of June 10, 2026 at 00:49 UTC)
| Price | USD 39.08 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 39.08 |
| Open | USD 39.08 |
| Day Range | USD 39.08 – 39.08 |
| 52-Week Range | USD 31.8 – 56.91 |
| Volume | 222 shares |
| Market Cap | $4.14B |
| Exchange | PNK |
Technical Analysis (HKMPY)
Nexqual's technical model rates HKMPY "BUY" based on 4 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 00:49 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 64.62 (neutral) |
| vs SMA50 | Above (USD 37.67) |
| MACD | 0.37 (positive) |
Analyst Ratings (HKMPY)
Wall Street analysts rate HKMPY "None", per Nexqual as of June 10, 2026 at 00:49 UTC.
| Consensus Rating | None |
|---|
Earnings (HKMPY)
Source: Nexqual, June 10, 2026 at 00:49 UTC.
Financials & Fundamentals (HKMPY)
| Total Revenue | $3.35B |
|---|---|
| Revenue Growth (YoY) | +8.50% |
| Gross Margin | +43.51% |
| Operating Margin | +16.20% |
| Profit Margin | +12.00% |
| ROE | +16.52% |
| Debt / Equity | 61.55 |
| Current Ratio | 1.82 |
| Total Cash | $243.00M |
| Total Debt | $1.60B |
| Free Cash Flow | $-66.13M |
Source: Nexqual, June 10, 2026 at 00:49 UTC.
Financial Health Score (HKMPY)
Nexqual rates HKMPY's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 00:49 UTC.
| Growth | Solid — Revenue +7% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 44%, operating 16% |
| Balance Sheet | Solid — $243M cash vs $1.60B debt |
| Cash Flow | Weak — FCF negative: -$66M, burning cash |
| Efficiency | Solid — ROE 17%, ROA 7.5% |
Ownership (HKMPY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.01% |
| Shares Outstanding | 106.01M |
| Float | 75.19M |
Source: Nexqual, June 10, 2026 at 00:49 UTC.
Leadership (HKMPY)
HKMPY is led by H.E Said Samih Taleb Darwazah (age 68), Chief Executive Officer, per Nexqual as of June 10, 2026 at 00:49 UTC.
| Chief Executive Officer | H.E Said Samih Taleb Darwazah (age 68) |
|---|---|
| Executive Vice Chairman & Deputy CEO of MENA | Mazen Samih Taleb Darwazah (age 67) |
| Deputy CEO of North America and Europe & Director | Khalid Walid Hussni Al Nabilsi (age 53) |
| VP, Group Financial Controller & Acting CFO | Areb AL KURDI (age 51) |
| Associate Director of Investor Relations | Guy Featherstone |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HKMPF | Hikma Pharmaceuticals plc. | USD 19.07 | ▼ 1.14% |
| IPSEY | Ipsen S.A. | USD 42.27 | ▼ 6.15% |
| HYPMY | Hypera SA | USD 3.96 | ▼ 5.71% |
| GNNDY | GN Store Nord A/S | USD 42.4 | ▼ 3.13% |
| OPHLY | Ono Pharmaceutical Co., Ltd. | USD 4.56 | ▲ 0.22% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:49 UTC. This page is informational and not investment advice.